Company Dynamic

VIRESTINA shows resistant weeds are pushing herbicide innovation back to the center of crop protection.

BASF’s price increase shows pharma excipients and APIs remain exposed to energy and raw material costs.

Lilly’s Indiana investment shows API capacity is now central to obesity drug competition.

ExxonMobil’s shutdown shows petrochemicals moving from expansion to harsh capacity rationalization.

The global MDI market is experiencing a rare regional divergence. Prices in North America have surged sharply, with some products rising by as much as USD 500–800/ton within a single day, while the Chinese market continues to weaken amid softening demand.

• MDI

The Syngenta protest shows crop protection giants face rising pressure over pollinator risk.

Since May 2026, the global chemical industry has entered a period of widespread weakness.

Lilly’s U.S. API investment shows pharma manufacturing is shifting toward localization and supply-chain control.

China’s agrochemical scale is becoming more influential as fertilizer and pesticide supply risks intensify.

China’s agrochemical scale is becoming more influential as fertilizer and pesticide supply risks intensify.

BASF has significantly expanded the global scale of its aroma ingredients supply chain through the construction of three world-scale production facilities under its aroma ingredients business division.

• BASF

BASF has significantly expanded the global scale of its aroma ingredients supply chain through the construction of three world-scale production facilities under its aroma ingredients business division.

• BASF

DuPont’s upgraded outlook shows how geopolitical shocks are being converted into pricing power across specialty materials.

BASF shows how inventory, delivery reliability, and supply-chain resilience are becoming new sources of chemical-sector advantage.

On May 2, 2026, China’s Ministry of Commerce issued Announcement No. 21, formally activating the Rules on Counteracting Unjustified Extraterritorial Application of Foreign Legislation and Other Measures.

BASF’s price hike shows how energy and raw-material inflation is feeding into pharma ingredients.

On April 29, Wanhua Chemical unveiled its 2026 investment plan. The company intends to invest RMB 27.3 billion in projects and RMB 2.22 billion in equity investments, bringing the total to nearly RMB 30 billion.

• wanhua chemical

Syngenta’s role in seeds and pesticides makes it vulnerable as U.S.-China farm trade tensions rise.

The Hormuz crisis shows India’s agrochemical strength still depends on vulnerable upstream chemical inputs.

The Hormuz crisis shows India’s agrochemical strength still depends on vulnerable upstream chemical inputs.